A Phase III Randomized, Double-blind, Clinical Trial of an Investigational Hexavalent Vaccine Given at Two, Three, Four and Twelve Months
Year: 2016
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Institution: University of Tampere
Language: English
Subfield: Microbiology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Funder: Sanofi Pasteur
OpenAlex ID: W2550976356
